Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 9 hours ago
Open | 8.60 |
High | 8.69 |
Low | 8.46 |
Mkt Cap | 2.05B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 8.59 |
52 Wk. Low | 4.92 |
52 Wk. High | 16.75 |
Related stocks
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 10.89M | 20.40% ▼ |
Net Income | -93M | - |
Diluted EPS | -0.42 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$0.42 | - |
Q4 2023 | -$0.45 | -$0.42 |
Q3 2023 | -$0.38 | -$0.43 |
S&P FuturesES=F | 5,244.00+5.00 (+0.10%) |
Dow FuturesYM=F | 39,590.00+54.00 (+0.14%) |
Nasdaq FuturesNQ=F | 18,225.50+11.00 (+0.06%) |
4.7500-1.25% | |
18.01+13.13% | |
30.42-22.06% |